Date | Title | Description |
18.05.2022 | adMare Appoints Dr. Christine Allen as Vice-President, Ecosy... | Toronto May 18, 2022 – adMare BioInnovations is pleased to announce the appointment of Dr. Christine... |
10.05.2022 | adMare BioInnovations joins a $42m Series A financing in Dom... | Strasbourg, France – Montreal, Canada – May 10, 2022 – Domain Therapeutics, a biopharmaceutical comp... |
03.05.2022 | adMare BioInnovations Collaborates with Accelerator Company,... | MONTREAL, QUEBEC, April 5, 2022 – Molecular Forecaster Inc. (MFI) is excited to announce a partnersh... |
02.05.2022 | adMare Portfolio Company, Zucara Therapeutics Secures Additi... | Toronto, Canada, May 2, 2022 – Zucara Therapeutics Inc., a diabetes life sciences company developing... |
15.04.2022 | Read the newest issue of the adMare Quarterly newsletter – A... | adMare Quarterly It has been a busy few months at adMare! From a transformative investment of $92M r... |
08.04.2022 | Building Canada’s Life Sciences Industry on a Strong Foundat... | Labour shortages are hitting virtually every Canadian sector, from coffee shops to car manufacturing... |
30.03.2022 | Government of Canada Invests $92 million in adMare to help t... | GOVERNMENT OF CANADA RELEASE
Government of Canada advances domestic life sciences sector by support... |
16.03.2022 | Listen to adMare’s President & CEO, Gordon C. McCauley o... | adMare’s President & CEO, Gordon C. McCauley speaks with Dr. Naveed Aziz on the first episode of... |
14.03.2022 | Join Us For adMare’s Global Leaders Webinar Featuring Dr. Ro... | adMare Global Leaders Webinar
From Lab bench to clinic: How to solve global health challenges by de... |
11.03.2022 | adMare supports Ukraine; Responds to Ministers Champagne and... | Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and... |
08.03.2022 | Join Us For adMare’s Lunch & Learn: Building Talent with... | The Amplitude Fellowship – Training the next generation of life science entrepreneurs
Are you an ou... |
14.02.2022 | adMare Portfolio Company, Find Therapeutics, Appoints Dr. Ph... | MONTREAL, Feb. 14, 2022 – Find Therapeutics Inc. (‘Find’) is pleased to announce accomplished biotec... |
08.02.2022 | adMare Portfolio Company, Zucara Therapeutics Announces Publ... | Toronto, Canada, February 8, 2022 – Zucara Therapeutics Inc., a diabetes life sciences company devel... |
17.01.2022 | Inversago Pharma, an adMare Portfolio Company, Completes Pha... | MONTREAL, Jan. 17, 2022 –Inversago Pharma Inc. (“Inversago”), the peripheral CB1 blockade company, a... |
13.01.2022 | adMare Portfolio Company NIMIUM Therapeutics’ Research Break... | MONTREAL, Jan. 11, 2022 – New research published in Nature Communications suggests that a newly-iden... |
12.01.2022 | adMare Portfolio Company Neurasic Therapeutics Receives New ... | Montréal – Québec – January 12th, 2022 –CQDM is pleased to announce a grant for a collaboration betw... |
16.12.2021 | Specific Biologics Closes Seed Financing with Industry Leade... | Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Duala... |
15.12.2021 | Join Us for adMare’s Industry Builder Webinar Featuring Dr. ... | Functional selectivity of GPCR signaling and its spatio-temporal propagation; Toward the design of b... |
18.11.2021 | adMare BioInnovations Announces Successful Applicants to 202... | Vancouver, BC and Montreal, QC (November 18, 2021) – adMare BioInnovations is pleased to announce th... |
15.11.2021 | adMare BioInnovations and uOttawa Work Together to Translate... | Vancouver, BC, and Ottawa, ON (November 15, 2021) – adMare BioInnovations is pleased to announce a c... |
09.11.2021 | adMare BioInnovations and CASTL Partner to Build Canada’s Bi... | Vancouver, BC and Charlottetown, PEI (November 9, 2021) – adMare BioInnovations and the Canadian All... |
02.11.2021 | adMare BioInnovations and District 3 Innovation partner to p... | MONTREAL, Quebec – November 2, 2021: District 3 Innovation Hub, an early-stage startup incubator loc... |
21.10.2021 | adMare’s President & CEO Gordon C. McCauley is Appointed... | Charlottetown, P.E.I. (October 21, 2021) – BIOVECTRA, a leading Canadian biotech and pharmaceutical ... |
28.09.2021 | adMare’s Accelerate Quebec Company, Molecular Forecaster, Co... | The company and its partners have secured CAD$1 million to apply and improve MFI’s virtual drug-desi... |
17.09.2021 | adMare Portfolio Company, Inversago Pharma Initiates a Phase... | MONTREAL (CANADA) – September 7th, 2021 – Inversago Pharma Inc. (“the Company” or “Inversago”), the ... |
29.07.2021 | Please wait while your request is being verified... | - |
03.06.2021 | CPDC/adMare Radiopharmaceutical Initiative (CARI): New blog ... | Over the past few months, adMare BioInnovations and the Centre for Probe Development and Commerciali... |
17.05.2021 | adMare and AazeinTx Inc Sign Global Exclusive Agreement | adMare BioInnovations (“adMare”) and AazeinTx Inc. (“AazeinTx”) have closed a global exclusive licen... |
12.04.2021 | adMare BioInnovations launches Canada’s first & only dig... | In our COVID world, we all need to get creative in building new ways to safely and effectively come ... |
10.02.2021 | Soundbite Medical Solutions Announces Health Canada Approval... | Soundbite announces Health Canada Approval for SoundBite Crossing System ‐ Peripheral (SCS-P) with t... |
10.02.2021 | Discover the Medical Isotope & Radiopharmaceutical Lands... | Did you know that Canada has been a global leader in the research, development and production of med... |
27.01.2021 | New Canadian Pharmaceutical Company Brings Novel Cancer Ther... | FORUS Therapeutics launches today, bringing a new pharmaceutical company onto the Canadian landscape... |
11.12.2020 | Join us in the 50 – 30 Challenge | adMare is proud to be an early adopter of the Government’s 50 – 30 Challenge to accelerate diversity... |
10.12.2020 | adMare BioInnovations Welcomes the First Quebec Start-Ups in... | adMare today unveiled the six companies selected under its new acceleration program supported by the... |
02.12.2020 | Event: Announcement of the Companies Selected Under adMare A... | adMare BioInnovations, Canada’s global life sciences venture, invites you to join us on Thursday, De... |
26.11.2020 | Radiopharmaceuticals: a new class of drugs for cancer patien... | The role of radiopharmaceuticals in health care may still be quite a mystery for many Canadians, but... |
26.11.2020 | adMare’s cross-Canada virtual roadtrip – British Columbia St... | COVID-19 may be keeping us from getting on planes and meeting in person, but it’s not stopping us fr... |
16.11.2020 | Developing Canada’s Next Generation of Commercial Life Scien... | adMare Academy Responds to Pandemic with New Pan-Canadian
BioInnovation Scientist Program
November... |
02.11.2020 | Zucara Therapeutics Expands ZT-01 Development Program to Typ... | – ZT-01 Development for T2D to be Supported by Nearly $450K in Non-Dilutive Funding –
Toronto, Cana... |
15.10.2020 | Didier Leconte Elected Chair of adMare Board | Vancouver and Montréal, Canada – October 15, 2020: adMare BioInnovations, Canada’s global life scien... |
17.09.2020 | Unleashing Canada’s Radiopharmaceutical Excellence | New Pan-Canadian Partnership Looks to Commercialize the Country’s Most Promising Radiopharmaceutical... |
14.09.2020 | Global Pandemic Drives Unprecedented Need to Grow Canada’s L... | adMare Academy Announces New Executive Institute Cohort
Vancouver and Montreal, Canada – September ... |
08.09.2020 | adMare is pleased to increase our investment in Inversago Ph... | Inversago Pharma closes US$35M Series B financing round and expands Board of Directors
Vancouver an... |
16.07.2020 | CDL Health and adMare BioInnovations partner to accelerate t... | Companies in CDL Health will benefit from adMare’s scientific and business expertise, infrastructure... |
26.06.2020 | adMare BioInnovations Strengthens Leadership Team | June 26, 2020 – adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce... |
08.06.2020 | Find Therapeutics, a new drug development company dedicated ... | The new company raises initial capital to develop transmembrane peptides against GPCRs to address hi... |
04.06.2020 | New Company to Advance Research into Made-in-Canada Therapy ... | Montreal, Canada – June 4, 2020: adMare BioInnovations, Canada’s Global Life Sciences Venture, along... |
21.05.2020 | adMare Academy Executive Institute – Developing Canada’s Lif... | Applications Now Open for 2020-2021 Program
Vancouver, Canada: adMare BioInnovations, Canada’s glob... |
21.04.2020 | On the Cutting-Edge of the Fight Against the Pandemic | Variational AI Receives Support from the Digital Technology Supercluster for Repurposing of Drugs fo... |
31.03.2020 | Zucara Therapeutics, an adMare & TIAP Spin-off Company, ... | Toronto, Canada – Zucara Therapeutics Inc., a diabetes life sciences company developing the first on... |
26.03.2020 | adMare and BELLUS Health Close Transaction for Intellectual ... | Montreal, QC: As announced Wednesday by BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the “Company” or... |
21.01.2020 | adMare Portfolio Company Receives FDA 510(k) Clearance | adMare BioInnovations Portfolio Company SoundBite Receives FDA 510(k) Clearance of the SoundBite™ Cr... |
09.01.2020 | adMare BioInnovations & Accel-Rx Unite to Advance the Ca... | Vancouver, Canada: With a shared vision to be a catalyst for Canadian life sciences leading the worl... |
18.11.2019 | adMare BioInnovations Appoints Dr. Mounia Azzi as Vice Presi... | Vancouver, BC and Montreal, QC: adMare BioInnovations, Canada’s Global Life Sciences Venture, is ple... |
- | - | Vancouver, Canada: CDRD, Canada’s national life sciences venture, has been selected for a Science Co... |
- | NEOMED Institute Launches NEOMED Therapeutics 1 Inc. to fund... | Christine Lennon named President & CEO
IND Qualifying Toxicology Studies Initiated for NEO2734
F... |
- | - | Ottawa and Vancouver, Canada: CDRD, The Centre for Drug Research and Development will be honoured wi... |
- | - | Vancouver, Canada: CDRD – The Centre for Drug Research and Development, Canada’s national drug devel... |
- | - | Vancouver, Canada: CDRD – The Centre for Drug Research and Development, Canada’s national life scien... |
- | NEO6860 Phase II Data to be Presented at the American Colleg... | – An analgesic effect demonstrated –
– No increase in body temperature nor change in heat pain perc... |
- | - | VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advan... |
- | - | Vancouver, Canada: CDRD, Canada’s national life sciences venture, is pleased to announce the appoint... |
- | adMare Academy Announces New Executive Institute Cohort to D... | Vancouver, Canada: The adMare Academy is pleased to announce the latest Canadian life science leader... |
- | - | Vancouver, Canada: CDRD – The Centre for Drug Research and Development, Canada’s national life scien... |
- | NEOMED Institute partners with McGill University to identify... | Montreal, Quebec, Canada May 3rd, 2018 – The NEOMED Institute announced today that it has entered in... |
- | Life Sciences & Health Technology Innovation Hub Takes S... | The NEOMED Innovation Centre will be expanded with the construction of a new innovation and commerci... |
- | - | CDRD – The Centre for Drug Research and Development, Canada’s national drug development and commerci... |
- | - | Share |
- | - | Typically occurring overnight, hypoglycemia puts over 8 million people with diabetes at fatal risk d... |
- | - | Vancouver, BC and Ottawa, ON: CDRD, Canada’s life sciences venture, TRIUMF, the country’s national p... |
- | adMare BioInnovations Launches a New Acceleration Program fo... | New program supported by the Quebec Government and the City of Montreal looks to scale-up the provin... |
- | adMare Launches Abdera with AbCellera as a Founding Partner | adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of A... |
- | Pave the road to successful commercialization of your radiop... | If you are an academic researcher or a biotech company looking to pave the road to successful commer... |
- | New Target for HIV Immune Therapy and Cure to be Explored by... | Montreal, Canada and London, UK: The NEOMED Institute (NEOMED), GlaxoSmithKline Inc. (GSK), the Cent... |
- | adMare Portfolio Company BELLUS Health Announces Positive In... | LAVAL, Quebec–(BUSINESS WIRE)–Sep. 13, 2021– BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Healt... |
- | - | Vancouver, Canada: CDRD, Canada’s national drug development and commercialization centre, congratula... |
- | - | CDRD is a proud sponsor of the TAT11 International Symposium on targeted alpha therapy hosted by Can... |
- | - | An op/ed piece submitted to the Canadian Science Policy Centre. You can find the original article he... |
- | Join Us on May 30th, for the Official Opening of adMare’s Mo... | adMare BioInnovations and BIOQuébec cordially invite you to join your fellow Quebec life sciences le... |
- | - | CDRD, Canada’s national drug development and commercialization centre, is pleased to share that “ZW4... |
- | - | Dr. Peter Bergqvist describes how some of his work contributed to a recent commercial outcome for Tx... |
- | adMare BioInnovations Appoints Dr. Youssef Bennani as Ventur... | Vancouver, BC and Montreal, QC: adMare BioInnovations, a pan-Canadian life sciences enterprise with ... |
- | Ingenuity in Canada’s life-sciences sector key piece in resp... | While celebrating the heroism of those on the front lines fighting this pandemic, we have reached th... |
- | CDRD & NEOMED Institute Join Forces to Create a New Pan-... | Vancouver, BC and Montreal, QC: Two successful Canadian innovation organizations, CDRD, Canada’s nat... |
- | - | Sepsis is the body’s over active and toxic response to an infection that causes hospitalization of m... |
- | - | Collaboration to utilize Schrodinger’s advanced computation platform technology to accelerate discov... |
- | Hope on the horizon for hard-to-treat breast cancers | Montreal, Canada – The NEOMED Institute (NEOMED), CQDM, the Canadian Cancer Society (CCS), the Goodm... |
- | - | Please add as a news item to CDRD website
Spring/Summer 2018 Communique
As Canada’s national life ... |
- | - | In celebration of Global Biotech Week, CDRD and BIOTECanada invite you to a thought-provoking evenin... |
- | - | Translational research is a high-risk, iterative phase of the drug development pipeline that is crit... |
- | - | Toronto and Vancouver, Canada: Zucara Therapeutics Inc., a diabetes life sciences company advancing ... |
- | New life sciences company takes aim at obesity, toxic effect... | A new made-in-Canada life sciences company, NIMIUM Therapeutics, has been launched to develop novel ... |
- | - | Toronto, Canada: The Centre for Drug Research and Development (CDRD), Canada’s national drug develop... |
- | - | To exemplify the collaborative spirit and leadership needed to advance the Canadian health and biosc... |
- | - | Welcome to CDRD – Built for Success
Every day is a revolution in life science in this world – from ... |
- | - | Vancouver, Canada – CDRD, Canada’s national life sciences venture, is pleased to announce an increas... |
- | - | Vancouver, Canada: CDRD, Canada’s national drug development and commercialization centre, is pleased... |